Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Neuropathology of Parkinson's Disease

Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556 · see citing works

ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE

Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,394 · see citing works

Cytotoxicity of microglia

Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,020 · see citing works

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works

Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms

Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686 · see citing works

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

Teismann, P., Tieu, K., Choi, D., Wu, D., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 659 · see citing works

Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People

Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., & Evans, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340202 · Cited by 659 · see citing works

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

Chen, H., Zhang, S. M., Hernán, M. Á., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 630 · see citing works

Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide

Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 562 · see citing works

Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis

Qiu, W. Q., & Folstein, M. F. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.004 · Cited by 538 · see citing works

Oxidative mechanisms in nigral cell death in Parkinson's disease.

Jenner, P. G. (1998) · PubMed · doi:10.1002/mds.870131304 · Cited by 511 · see citing works

Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons

Gao, H., Hong, J., Zhang, W., & Liu, B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · see citing works

Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects

UNGER, J., Livingston, J. H., & Moss, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 403 · see citing works

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 393 · see citing works

The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System

Herrera, A. J., Castaño, A., Venero, J. L., Cano, J., & Machado, A. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0289 · Cited by 392 · see citing works

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

Dehmer, T., Heneka, M. T., Sastre, M., DICHGANS, J., & Schulz, J. B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382 · see citing works

Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease

Breidert, T., Callebert, J., Heneka, M. T., Landreth, G. E., Launay, J., & Hirsch, É. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 375 · see citing works

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works

The role of glial cells in Parkinsonʼs disease

Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326 · see citing works

Synaptic Mitochondria Are More Susceptible to Ca2+Overload than Nonsynaptic Mitochondria

Brown, M. R., Sullivan, P. G., & Geddes, J. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510303200 · Cited by 297 · see citing works

Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity

Crouser, E. D., JULIAN, M. W., Blaho, D. V., & Pfeiffer, D. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00002 · Cited by 277 · see citing works

Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death

Sullivan, P. G., Dubé, C. M., Dorenbos, K., Steward, O., & Baram, T. Z. (2003) · Annals of Neurology · doi:10.1002/ana.10543 · Cited by 251 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Greenamyre, J. T., MacKenzie, G. M., Peng, T., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248 · see citing works

Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.

Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247 · see citing works

Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease

Vijitruth, R., Liu, M., Choi, D., Nguyen, X. V., Hunter, R. L., & Bing, G. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-6 · Cited by 236 · see citing works

Chapter 36: Astrocytes and Parkinson's disease

Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. A. D., & Langston, J. W. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230 · see citing works

Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo.

Hagg, T., & Varon, S. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6315 · Cited by 229 · see citing works

Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration.

Arimoto, T., & Bing, G. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00017-7 · Cited by 202 · see citing works

Neuronal vulnerability in Parkinson’s disease

Hirsch, É. C., Faucheux, B. A., Damier, P., Prigent, A., & Agid, Y. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192 · see citing works

Pioglitazone: mechanism of action.

Smith, U. (2001) · PubMed · Cited by 171 · see citing works

Systemic Infusion of Naloxone Reduces Degeneration of Rat Substantia Nigral Dopaminergic Neurons Induced by Intranigral Injection of Lipopolysaccharide

Liu, B., Jiang, J., Wilson, B. C., Du, L., Yang, S., Wang, J., Wu, G.-C., Cao, X.-D., & Hong, J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38877-9 · Cited by 167 · see citing works

Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38

Xie, Z., Smith, C. J., & Eldik, L. J. V. (2003) · Glia · doi:10.1002/glia.10314 · Cited by 164 · see citing works

Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra

Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P. C. W., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R. J., & Hong, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160 · see citing works

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease

Moroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P., Mcgeer, E., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 149 · see citing works

Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra

Arimoto, T., Choi, D., Lü, X., Liu, M., Nguyen, X. V., Zheng, N., Stewart, C. A., Kim, H., & Bing, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.011 · Cited by 149 · see citing works

Insulin receptor mRNA in the substantia nigra in Parkinson's disease.

Takahashi, M., Yamada, T., Tooyama, I., Moroo, I., Kimura, H., Yamamoto, T., & Okada, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12357-0 · Cited by 131 · see citing works

Nitrogen disruption of synaptoneurosomes: an alternative method to isolate brain mitochondria

Brown, M. R., Sullivan, P. G., Dorenbos, K., Modafferi, E. F., Geddes, J. W., & Steward, O. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.02.028 · Cited by 114 · see citing works

Postencephalitic parkinsonism – a review

Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 105 · see citing works

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat

Cass, W. A., Harned, M. E., Peters, L. E., Nath, A., & Maragos, W. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03122-6 · Cited by 100 · see citing works

Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats

Lu, X., Bing, G., & Hagg, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00033-6 · Cited by 89 · see citing works

Inhibitory action of minocycline on lipopolysaccharide-lnduced release of nitric oxide and prostaglandin E2 in BV2 microglial cells

Kim, S., Kong, P., Kim, B.-S., Sheen, D., Nam, S.-Y., & Chun, W. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980066 · Cited by 81 · see citing works

Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits

Zhang, J., Stanton, D. M., Nguyen, X. V., Liu, M., Zhang, Z., Gash, D. M., & Bing, G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.049 · Cited by 64 · see citing works

ULTRASTRUCTURAL CHANGES IN SKELETAL MUSCLE MITOCHONDRIA IN GRAM-NEGATIVE SEPSIS

Welty‐Wolf, K. E., Simonson, G., Huang, Y.-C. T., Fracica, P. J., Patterson, J., & Piantadosi, C. A. (1996) · Shock · doi:10.1097/00024382-199605000-00011 · Cited by 52 · see citing works

LPS-induced apoptosis is dependent upon mitochondrial dysfunction

Kuwabara, T., & Imajoh‐Ohmi, S. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000031453.90821.6a · Cited by 41 · see citing works

Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection

Hsieh, P. F., Chia, L., Ni, D.-R., Cheng, L.-J., Ho, Y.-P., Tzeng, S., Chang, M.-H., & Hong, J. (2002) · Neuroreport · doi:10.1097/00001756-200203040-00006 · Cited by 36 · see citing works

Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration

Schiess, M. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1043 · Cited by 34 · see citing works

Parkinson's disease: Neurodegenerative mechanisms and neuroprotective interventions—report of a workshop

Fahn, S., Clarence‐Smith, K., & Chase, T. N. (1998) · Movement Disorders · doi:10.1002/mds.870130502 · Cited by 28 · see citing works

Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7‐day‐old rat

Jones, K. L., & Barr, G. A. (2000) · Synapse · doi:10.1002/1098-2396(200102)39:2 · Cited by 11 · see citing works

Microglia mediated dopaminergic cell death in the substantia nigra: A new animal model for Parkinson's disease

Floyd, R. A. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)90128-9 · Cited by 10 · see citing works

Clinical neurovirology

Davis, L. E. (2004) · Annals of Neurology · doi:10.1002/ana.20132 · Cited by 10 · see citing works

[Diabetes mellitus in parkinsonism patients].

Chalmanov, V., & Vŭrbanova, M. (1987) · PubMed · Cited by 9 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8249(200011)48:5

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805 · see citing works

Basic mechanisms of neurodegeneration: a critical update

Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 608 · see citing works

An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging

Sayed, N., Huang, Y., Nguyen, K., Krejciova-Rajaniemi, Z., Grawe, A. P., Gao, T., Tibshirani, R., Hastie, T., Alpert, A., Cui, L., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00082-y · Cited by 572 · see citing works

Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration

Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529 · see citing works

Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats

Jin, F. J., Wu, Q., Lu, Y., Gong, Q., & Shi, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384 · see citing works

Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation

Bureau, G., Longpré, F., & Martinoli, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21503 · Cited by 336 · see citing works

The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes

Niranjan, R. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8483-x · Cited by 331 · see citing works

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · see citing works

PPARs in the brain

HENEKA, M., & LANDRETH, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.016 · Cited by 317 · see citing works

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 275 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Parkinson's disease, insulin resistance and novel agents of neuroprotection

Avilés-Olmos, I., Limousin, P. D., Lees, A. J., & Foltynie, T. (2012) · Brain · doi:10.1093/brain/aws009 · Cited by 284 · see citing works

PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease

Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 259 · see citing works

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders

Urrutia, P. J., Mena, N. P., & Núñez, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00038 · Cited by 246 · see citing works

The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery

Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · see citing works

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease

Cheong, J. L. Y., Pablo‐Fernández, E. D., Foltynie, T., & Noyce, A. J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191900 · Cited by 230 · see citing works

Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity

Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D. Y., Hunter, R. L., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 223 · see citing works

Inflammation in the early stages of neurodegenerative pathology

Khandelwal, P. J., Herman, A. M., & Moussa, C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 211 · see citing works

Lipopolysaccharide Animal Models for Parkinson's Disease

Liu, M., & Bing, G. (2011) · Parkinson s Disease · doi:10.4061/2011/327089 · Cited by 191 · see citing works

Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions

Dovonou, A., Bolduc, C., Linan, V. S., Gora, C., Peralta, M. R., & Lévesque, M. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00368-8 · Cited by 203 · see citing works

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

Troncoso-Escudero, P., Parra, A., Nassif, M., & Vidal, R. L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00860 · Cited by 191 · see citing works

Preconditioning provides neuroprotection in models of CNS disease: Paradigms and clinical significance

Stetler, R. A., Leak, R. K., Gan, Y., Li, P., Zhang, F., Hu, X., Zheng, J., Chen, J., Zigmond, M. J., & Gao, Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.005 · Cited by 189 · see citing works

Mechanisms of chemotherapy-induced behavioral toxicities

Vichaya, E. G., Chiu, G. S., Krukowski, K., Lacourt, T. E., Kavelaars, A., Dantzer, R., Heijnen, C. J., & Walker, A. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00131 · Cited by 189 · see citing works

The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

Swanson, C. R., Joers, V. L., Bondarenko, V., Brunner, K. G., Simmons, H. A., Ziegler, T. E., Kemnitz, J. W., Johnson, J. A., & Emborg, M. E. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-91 · Cited by 187 · see citing works

Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease

Grimm, A., Friedland, K., & Eckert, A. (2015) · Biogerontology · doi:10.1007/s10522-015-9618-4 · Cited by 182 · see citing works

Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders

Agarwal, S., Yadav, A., & Chaturvedi, R. K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.043 · Cited by 181 · see citing works

Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications

Scaini, G., Rezin, G. T., Carvalho, A. F., STRECK, E. L., Berk, M., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.040 · Cited by 184 · see citing works

Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease

Quintanilla, R. A., & Johnson, G. V. W. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.010 · Cited by 173 · see citing works

PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s

Corona, J. C., & Duchen, M. R. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1377-0 · Cited by 169 · see citing works

The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

Yamamoto, B. K., & Raudensky, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9121-7 · Cited by 167 · see citing works

Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish

Lee (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2010.571 · Cited by 165 · see citing works

Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases

Cao, S. S., Luo, K. L., & Shi, L. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25098 · Cited by 163 · see citing works

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

Fellner, L., Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0833-z · Cited by 162 · see citing works

Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury

Sauerbeck, A. D., Gao, J., Readnower, R. D., Liu, M., Pauly, J. R., Bing, G., & Sullivan, P. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.003 · Cited by 156 · see citing works

Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System

Bournival, J., Plouffe, M., Renaud, J., Provencher, C., & Martinoli, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/921941 · Cited by 150 · see citing works

PPAR: a therapeutic target in Parkinson’s disease

Chaturvedi, R. K., & Beal, M. F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05388.x · Cited by 147 · see citing works

Parkinson’s disease and enhanced inflammatory response

Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215576313 · Cited by 146 · see citing works

Battery of behavioral tests in mice to study postoperative delirium

Peng, M., Zhang, C., Dong, Y., Zhang, Y., Nakazawa, H., Kaneki, M., Zheng, H., Shen, Y., Marcantonio, E. R., & Xie, Z. (2016) · Scientific Reports · doi:10.1038/srep29874 · Cited by 148 · see citing works

Striatal Neuroinflammation Promotes Parkinsonism in Rats

Choi, D.-Y., Liu, M., Hunter, R. L., Cass, W. A., Pandya, J. D., Sullivan, P. G., Shin, E.-J., Kim, H.-C., Gash, D. M., & Bing, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005482 · Cited by 141 · see citing works

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

Kim, S., Kang, H., Jhon, M., Kim, J., Lee, J., Walker, A. J., Agustini, B., Kim, J., & Berk, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00103 · Cited by 137 · see citing works

Microglial responses to dopamine in a cell culture model of Parkinson's disease

Mastroeni, D., Grover, A., Leonard, B. W., Joyce, J. N., Coleman, P. D., Kozik, B., Bellinger, D. L., & Rogers, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.001 · Cited by 130 · see citing works

Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells

Quintanilla, R. A., Jin, Y. N., Fuenzalida, K. M., Bronfman, M., & Johnson, G. V. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804291200 · Cited by 126 · see citing works

Immature Dentate Gyrus: An Endophenotype of Neuropsychiatric Disorders

Hagihara, H., Takao, K., Walton, N. M., Matsumoto, M., & Miyakawa, T. (2013) · Neural Plasticity · doi:10.1155/2013/318596 · Cited by 123 · see citing works

Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt

Xing, B., Xin, T., Hunter, R. L., & Bing, G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-4 · Cited by 122 · see citing works

Updates on immunity and inflammation in Parkinson disease pathology

Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 118 · see citing works

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease

Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 120 · see citing works

Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone

Anderson, D. G., Mariappan, S. V. S., Buettner, G. R., & Doorn, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249532 · Cited by 117 · see citing works

Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat

Hoban, D. B., Connaughton, E., Connaughton, C., Hogan, G., Thornton, C., Mulcahy, P. J., Moloney, T. C., & Dowd, E. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.001 · Cited by 113 · see citing works

Protective Microglia and Their Regulation in Parkinson’s Disease

Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112 · see citing works

Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease

Ghosh, A., Langley, M. R., Harischandra, D. S., Neal, M. P., Jin, H., Anantharam, V., Joseph, J., Brenza, T. M., Narasimhan, B., Kanthasamy, A., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9650-4 · Cited by 107 · see citing works

Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats

Liu, M., Choi, D., Hunter, R. L., Pandya, J. D., Cass, W. A., Sullivan, P. G., Kim, H., Gash, D. M., & Bing, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06497.x · Cited by 110 · see citing works

Ethanolic Extract of Fructus Alpinia oxyphylla Protects Against 6-Hydroxydopamine-Induced Damage of PC12 Cells In Vitro and Dopaminergic Neurons in Zebrafish

Zhang, Z., Cheang, L. C.-V., Wang, M.-W., Li, G., Chu, I. K., Lin, Z., & Lee, S. M. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9731-0 · Cited by 110 · see citing works

Dopamine: an immune transmitter

Broome, S. T., Louangaphay, K., Keay, K. A., Leggio, G. M., Musumeci, G., & Castorina, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284976 · Cited by 109 · see citing works

SpirulinaandC-phycocyaninreduce cytotoxicity and inflammation-related genes expression of microglial cells

Chen, J.-C., Liu, K. S., Yang, T.-J., Hwang, J.-H., Chan, Y., & Lee, I. (2012) · Nutritional Neuroscience · doi:10.1179/1476830512y.0000000020 · Cited by 109 · see citing works

PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders

Doorduin, J., de Vries, E. F. J., Dierckx, R. A. J. O., & Klein, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549443 · Cited by 107 · see citing works

Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease

Koppula, S., Kumar, H., Kim, I. S., & Choi, D. (2012) · Mediators of Inflammation · doi:10.1155/2012/823902 · Cited by 107 · see citing works

Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis—A Review

Shin, E., Tran, H., Nguyen, P. T., Jeong, J. H., Nah, S.-Y., Jang, C., Nabeshima, T., & Kim, H. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2318-5 · Cited by 108 · see citing works

The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease

Tüfekçi, K. U., Genç, Ş., & Genç, K. (2011) · Parkinson s Disease · doi:10.4061/2011/487450 · Cited by 108 · see citing works

Inflammation, mitochondria, and the inhibition of adult neurogenesis

Voloboueva, L. A., & Giffard, R. G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22768 · Cited by 106 · see citing works

Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease

Kumar, P., Kaundal, R. K., More, S. V., & Sharma, S. S. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.010 · Cited by 105 · see citing works

Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease

Gordon, R., Singh, N., Lawana, V., Ghosh, A., Harischandra, D. S., Jin, H., Hogan, C., Sarkar, S., Rokad, D., Panicker, N., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.008 · Cited by 105 · see citing works

Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease

Koutzoumis, D. N., Vergara, M., Pino, J. A., Buddendorff, J., Khoshbouei, H., Mandel, R. J., & Torres, G. E. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113159 · Cited by 103 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease

Onyango, I. G. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9482-y · Cited by 100 · see citing works

Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice

Hunter, R. L., Cheng, B., Choi, D., Liu, M., Liu, S., Cass, W. A., & Bing, G. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22012 · Cited by 100 · see citing works

Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia

Brown, J. S. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm147 · Cited by 100 · see citing works

Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease

Kaur, K., Gill, J. S., Bansal, P. K., & Deshmukh, R. R. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3251 · Cited by 98 · see citing works

Drug Insight: effects mediated by peroxisome proliferator-activated receptor-γ in CNS disorders

Heneka, M. T., Landreth, G. E., & Hüll, M. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0586 · Cited by 96 · see citing works

Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide

Dang, R., Zhou, X., Tang, M., Xu, P., Gong, X., Liu, Y., Jiao, H., & Jiang, P. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1373-z · Cited by 93 · see citing works

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Chatterjee, D., Bhatt, M. A., Butler, D., Genst, E. D., Dobson, C. M., Messer, A. C., & Kordower, J. H. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0062-4 · Cited by 93 · see citing works

Modeling neuroinflammatory pathogenesis of Parkinson’s disease

Barnum, C. J., & Tansey, M. G. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84006-3 · Cited by 91 · see citing works

PPAR Agonists as Therapeutics for CNS Trauma and Neurological Diseases

Mandrekar-Colucci, S., Sauerbeck, A. D., Popovich, P. G., & McTigue, D. M. (2013) · ASN NEURO · doi:10.1042/an20130030 · Cited by 91 · see citing works

Protective effects of resveratrol on mitochondrial function in the hippocampus improves inflammation-induced depressive-like behavior

Chen, W., Du, J.-K., Hu, X., Yu, Q., Li, D., Wang, C.-N., Zhu, X., & Liu, Y. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.09.024 · Cited by 91 · see citing works

Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets

Yang, L., Mao, K., Yu, H., & Chen, J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09926-7 · Cited by 90 · see citing works

LPS-induced oxidative stress and inflammatory reaction in the rat striatum

Noworyta, K., Górska, A. M., & Gołembiowska, K. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71067-3 · Cited by 87 · see citing works

The Potential Effects of Phytoestrogens: The Role in Neuroprotection

Gorzkiewicz, J., Bartosz, G., & Sadowska‐Bartosz, I. (2021) · Molecules · doi:10.3390/molecules26102954 · Cited by 86 · see citing works

A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue

Jaquins‐Gerstl, A., & Michael, A. C. (2015) · The Analyst · doi:10.1039/c4an02065k · Cited by 85 · see citing works

Mitochondrial respiratory chain and creatine kinase activities in rat brain after sepsis induced by cecal ligation and perforation

Comim, C. M., Rezin, G. T., Scaini, G., Di‐Pietro, P. B., Cardoso, M. R., Petronilho, F. C., Ritter, C., STRECK, E. L., Quevedo, J., & Dal‐Pizzol, F. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.07.002 · Cited by 83 · see citing works

Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

Lama, J., Buhidma, Y., Fletcher, E. J. R., & Duty, S. (2021) · Neuronal Signaling · doi:10.1042/ns20210026 · Cited by 86 · see citing works

Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool

Quintão, N. L. M., Santin, J. R., Stoeberl, L. C., Corrêa, T. P., Melato, J., & da Costa, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00907 · Cited by 81 · see citing works

Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders

Yanuck, S. F. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00712 · Cited by 80 · see citing works

Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of COX-2 activity

Xing, B., Liu, M., & Bing, G. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.029 · Cited by 78 · see citing works

Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide

Beier, E. E., Neal, M. P., Alam, G., Edler, M. K., Wu, L., & Richardson, J. R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.009 · Cited by 76 · see citing works

Distinct modulation of voltage‐gated and ligand‐gated Ca2+ currents by PPAR‐γ agonists in cultured hippocampal neurons

Pancani, T., Phelps, J. T., Searcy, J. L., Kilgore, M. W., Chen, K.-C., Porter, N. M., & Thibault, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06107.x · Cited by 75 · see citing works

Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats

Hunter, R. L., Choi, D., Ross, S. A., & Bing, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.019 · Cited by 74 · see citing works

Impact of Traumatic Brain Injury on Dopaminergic Transmission

Chen, Y.-H., Huang, E. Y., Kuo, T., Miller, J., Chiang, Y. H., & Hoffer, B. J. (2017) · Cell Transplantation · doi:10.1177/0963689717714105 · Cited by 74 · see citing works

Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line

Holmes, S., Singh, M., Su, C., & Cunningham, R. L. (2016) · Endocrinology · doi:10.1210/en.2015-1738 · Cited by 73 · see citing works

Quercetin Protects Obesity-Induced Hypothalamic Inflammation by Reducing Microglia-Mediated Inflammatory Responses via HO-1 Induction

Yang, J., Kim, C.-S., Tu, T. H., Kim, M., Goto, T., Kawada, T., Choi, M., Park, T., Sung, M., Yun, J. W., et al. (2017) · Nutrients · doi:10.3390/nu9070650 · Cited by 73 · see citing works

Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats

Bonato, J. M., Bassani, T. B., Milani, H., Vital, M. A. B. F., & de Oliveira, R. M. W. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.009 · Cited by 72 · see citing works

Luteolin Inhibits Microglial Inflammation and Improves Neuron Survival Against Inflammation

Zhu, L.-H., Bi, W., Qi, R., Wang, H., & Lu, D. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.569040 · Cited by 71 · see citing works

Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?

Carta, A. R., & Pisanu, A. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9342-7 · Cited by 70 · see citing works

Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ

Shin, E., Duong, C., Nguyen, X. T., Li, Z., Bing, G., Bach, J., Park, D.-H., Nakayama, K. I., Ali, S. F., Kanthasamy, A., et al. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.001 · Cited by 76 · see citing works

Microglia Receptors in Animal Models of Traumatic Brain Injury

Younger, D., Murugan, M., Rao, K. V. R., Wu, L., & Chandra, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1428-7 · Cited by 69 · see citing works

Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats

Fan, L.-W., Kaizaki, A., Tien, L., Pang, Y., Tanaka, S., Numazawa, S., Bhatt, A., & Cai, Z. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.041 · Cited by 70 · see citing works

Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases

Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 76 · see citing works

Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats

Lee, E. Y., Lee, J. E., Park, J. H., Shin, I. C., & Koh, H. C. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.016 · Cited by 69 · see citing works

Initial management of Parkinson's disease

Goetz, C. G., & Pal, G. D. (2014) · BMJ · doi:10.1136/bmj.g6258 · Cited by 68 · see citing works

Parkinson';s Disease, Diabetes and Cognitive Impairment

Ashraghi, M. R., Pagano, G., Polychronis, S., Niccolini, F., & Politis, M. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810999160628105549 · Cited by 68 · see citing works

Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach

Zanardelli, M., Micheli, L., Cinci, L., Failli, P., Ghelardini, C., & Mannelli, L. D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102758 · Cited by 65 · see citing works

Lipopolysaccharide-induced functional and structural injury of the mitochondria in the nigrostriatal pathway

Hunter, R. L., Ojha, U., Bhurtel, S., Bing, G., & Choi, D. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.09.007 · Cited by 42 · see citing works

Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings

Zamanian, M. Y., Terefe, E. M., Taheri, N., Kujawska, M., Tork, Y. J., Abdelbasset, W. K., Shoukat, S., Opulencia, M. J. C., Heidari, M., & Alesaeidi, ‬. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221005122408 · Cited by 31 · see citing works

Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats

Hunter, R. L., Choi, D., Ross, S. A., & Bing, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.019 · Cited by 74 · see citing works

Striatal Neuroinflammation Promotes Parkinsonism in Rats

Choi, D.-Y., Liu, M., Hunter, R. L., Cass, W. A., Pandya, J. D., Sullivan, P. G., Shin, E.-J., Kim, H.-C., Gash, D. M., & Bing, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005482 · Cited by 141 · see citing works

Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease

Hunter, R. L., & Bing, G. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077123 · Cited by 60 · see citing works